27787

27787
U.S. Food and Drug Administration (FDA). FDA review finds no significant increase in risk of serious asthma outcomes with long-acting beta agonists (LABAs) used in combination with inhaled corticosteroids (ICS). 2017 [cited: 2018-02-22]. http://www.fda.gov/downloads/Drugs/DrugSafety/UCM589997.pdf
Einstellungen
27787
nein
Kategorisierung
Sitemap
nein
Wird geladen
zuletzt verändert: 25.01.2021 | 18:45 Uhr